Stock/Equity-Based Compensation - Summary of Stock Option Activity (Detail) - USD ($)	3 Months Ended	12 Months Ended
Mar. 31, 2022	Dec. 31, 2021
Number of Shares/Units
Outstanding at December 31, 2021	1,779,174
Granted	17,000
Exercised
Forfeited	(246,808)
Outstanding as of March 31, 2022	1,549,366	1,779,174
Vested and expected to vest as of March 31, 2022	1,549,366
Weighted Average Exercise Price
Outstanding as of December 31, 2021	$ 18.99
Granted	2.89
Exercised
Forfeited	14.60
Outstanding as of March 31, 2022	19.30	$ 18.99
Vested and expected to vest as of March 31, 2022	$ 19.30
Weighted Average Remaining Contractual Term, Outstanding	7 years 5 months 15 days	7 years 8 months 1 day
Weighted Average Remaining Contractual Term,Granted
Weighted Average Remaining Contractual Term,Exercised
Weighted Average Remaining Contractual Term,Forfeited
Vested and expected to vest as of March 31, 2021	7 years 5 months 15 days
Aggregate Intrinsic Value, Outstanding as of December 30, 2021
Aggregate Intrinsic Value,Granted
Aggregate Intrinsic Value,Exercised
Aggregate Intrinsic Value,Forfeited
Weighted Average Remaining Contractual Term,Forfeited
Aggregate Intrinsic Value, Vested and expected to vest at September 30, 2021

Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.